Shares of Cerus Corporation (NASDAQ:CERS) ended Monday session in green amid volatile trading. The shares closed up +0.05 points or 0.81% at $6.26 with 427,923.00 shares getting traded. Post opening the session at $6.21, the shares hit an intraday low of $6.12 and an intraday high of $6.34 and the price vacillated in this range throughout the day. The company has a market cap of $652.42 million and the numbers of outstanding shares have been calculated to be 102.71 million shares.
Cerus Corporation (CERS), a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, including viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
Shares of Hologic, Inc. (NASDAQ:HOLX) ended Monday session in green amid volatile trading. The shares closed up +0.05 points or 0.13% at $38.88 with 2.54 million shares getting traded. Post opening the session at $38.54, the shares hit an intraday low of $38.39 and an intraday high of $38.95 and the price vacillated in this range throughout the day. The company has a market cap of $10.98 billion and the numbers of outstanding shares have been calculated to be 277.42 million shares.
Hologic, Inc. (HOLX) announced that it plans to release its financial results for the fourth quarter of fiscal 2016 on Wednesday, November 2, 2016, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing 877-548-7906 (in the United States) or 719-325-4923 (for international callers) and referencing access code 8610000. Participants should dial in 5-10 minutes before the call begins. A replay will be available approximately two hours after the call ends through Friday, November 25, 2016. The replay numbers are 888-203-1112 (U.S.) or 719-457-0820 (international), access code 8610000, Pin 9876.
Hologic will provide a live webcast of the call on the Company’s website at http://investors.hologic.com, and the call will be archived there for 30 days.